HLB Co. Ltd. (028300)
028300 · Health Care · 
Korea
HLB Co. Ltd. (028300) is a company in the Health Care sector, based in Korea. The stock is held in 4 ETFs we track – with its largest weight of 0.02 % in IS3N (msci-em-imi). Anyone holding one of these ETFs also owns a small indirect stake in HLB.
How many funds hold this stock?
Average ETF coverage: 4 of the 95 ETFs we cover hold HLB, spread across 3 indices. That puts the stock in more ETFs than 40.7 % of the 4,334 stocks we cover.
The line counts the funds we cover, not the market. Dashed: how many funds published a holdings list on that date.
What ETF is HLB in?
| ETF | Index | Weight | per €1,000 in the ETF |
|---|---|---|---|
| IS3N | msci-em-imi | 0.02 % | €0.20 |
| SPYI / SPSA | msci-acwi-imi | 0.00 % | €0.00 |
| IUSQ | msci-acwi | 0.00 % | €0.00 |
The last column turns the weight into euros: this much of €1,000 invested in one of these funds is allocated to HLB as of the fund's latest holdings list.
Weight in IS3N since 2019
In IS3N, a fund tracking the MSCI EM IMI, HLB had a weight of 0.03 % on Sep 30, 2019 and 0.02 % on Sep 18, 2026. Its share peaked at 0.11 % on Mar 29, 2024. The weight rises and falls with the stock's price relative to the other index members, and it also shifts when the index provider changes the composition.
How much HLB Co. Ltd. overlaps with other holdings in a portfolio is shown by the What's Inside Your ETF Portfolio and the ETF overlap check.
Stocks with similar ETF exposure
Names that reach a portfolio through largely the same funds as HLB — the figure counts the ETFs holding both.
| Stock | Ticker | Shared ETFs | r |
|---|---|---|---|
| Sam Chun Dang Pharm. Co. Ltd. | 000250 | 3 | – |
| Daewoong Co. Ltd. | 003090 | 3 | – |
| GC Biopharma Corp. | 006280 | 3 | – |
| NATURECELL Co. Ltd. | 007390 | 3 | – |
| Hanmi Science Co. Ltd | 008930 | 3 | – |
| Hanall Biopharma Co. Ltd. | 009420 | 3 | – |
| Oscotec Inc. | 039200 | 3 | – |
| Celltrion Pharm Inc. | 068760 | 3 | – |
